The following conditions are very much prevalent in people with NAFLD and research has established them and you are at risk of NAFLD if you have any of the following
NAFLD
The following conditions are very much prevalent in people with NAFLD and research has established them and you are at risk of NAFLD if you have any of the following
If your daily diet consists of high intake of calorie rich food consisting of sugars, fats and carbohydrates and you sit for long hours without any room for physical exercise in your day-to-day life then you are at high risk of NAFLD.
Being over weight or obese especially excess weight around the tummy area (central obesity) will put you at the risk of NAFLD. More than 95% of the severely obese people undergoing bariatric surgery for reducing weight are known to have NAFLD.
IR is a condition where the cells do not respond to insulin hormone, which is required for the uptake and utilization of glucose (sugar) from blood for energy production
Not just metabolic syndrome even a single feature of metabolic syndrome will raise your risks of NAFLD. A metabolic syndrome is a group of disease characters that are linked to overweight and obesity.
Presence of any of the following three or more of the features can be considered as metabolic syndrome
If you are a type 2 diabetic then chances are high that you may have NAFLD as in one study it was found that nearly 1/3rd to 2/3rd of patients with type 2 diabetes have NAFLD. It is a well-established fact that both type 2 diabetes and NAFDL are so much interlinked that both can develop almost at the same time.
“Dys” means abnormal, “lipid” means fat and “emia” means in the blood. High levels of triglycerides (a type of fat) and abnormal levels of cholesterol, with high total cholesterol, high LDL or low HDL cholesterol all contribute to risk of NAFLD. Studies have shown that more than 50% of patients with dyslipidemia have NAFLD.
With advancing age the risk of developing NAFLD increases
It is believed that males have two times higher risk of NAFLD than females
Reference:
Chalasani, N. , Younossi, Z. , Lavine, J. E., Charlton, M. , Cusi, K. , Rinella, M. , Harrison, S. A., Brunt, E. M. and Sanyal, A. J. (2018), The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67: 328-357. doi:10.1002/hep.29367